Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.
about
Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in ChinaSubstitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor ResistanceClinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.
P2860
Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Generation of a chimeric hepat ...... and drug-associated mutations.
@en
type
label
Generation of a chimeric hepat ...... and drug-associated mutations.
@en
prefLabel
Generation of a chimeric hepat ...... and drug-associated mutations.
@en
P2093
P50
P356
P1433
P1476
Generation of a chimeric hepat ...... and drug-associated mutations
@en
P2093
Adriana Gaeguta
Amanda L Aloia
John A Howe
Robert Chase
Stephen Locarnini
Stuart Black
Sumudu K Narayana
Zhuyan Guo
P304
P356
10.3851/IMP2850
P577
2014-09-15T00:00:00Z